1. Banavali SD, Advani SH, A hypothetical model to explain the ‘termination’ of chronic myeloid leukemia into blastic crisis. Med Hypotheses 34: 111, 1991
2. Gale RP, Grosveld G, Canaani E, Goldman JM, Chronic myelogenous leukemia: biology and therapy. Leukemia 7: 653, 1993
3. Guerrasio A, Martinelli G, Saglio G, Rosso C, Zaccaria A, Rosti G, Testoni N, Ambrosetti A, Izzi T, Sessarego M, Frassoni F, Gasparini P, Chiamenti A, Di Bartolomeo P, Pignatti PF, Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogenic bone marrow transplants. Leukemia 6: 507, 1992
4. Hehlmann R, Heimpel H, Griesshammer M, Kolb HJ, Heinze B, Hossfeld DK, Wickramanayake PD, Essers U, Thiele J, Georgii A, Ansari H, Hochhaus A, Hasford J, the German Study Group, Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. Leukemia 6 [Suppl 3]: 110 S, 1992
5. Kawakubo K, Ohyashiki JH, Ohyashiki K, Tauchi T, Ohto T, Toyama K, Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph-positive CML treated with alpha interferon. Cancer Genet Cytogenet 58: 165, 1992